Biosciences

The Colorado BioScience Association (CBSA), which creates co-opportunity for Colorado’s life sciences community by championing a collaborative ecosystem and advocating for a supportive business climate, announces new leadership for its Board of Directors and welcomes new board members, including Hannah Nelson, associate director of licensing at Venture Partners at CU Boulder.

CU Boulder College of Engineering & Applied Science—William Frantz didn’t walk away with the top prize at this year’s Lab Venture Challenge (LVC), but his research may still be a winner for future cancer patients. Frantz is developing microscopic droplets designed to help doctors track radiation therapy in real time, technology that could one day make cancer treatment more precise and less harmful, particularly for pediatric patients.

CU Boulder Today—A neural circuit hidden in an understudied region of the brain plays a critical role in turning temporary pain into pain that can last months or years, according to new University of Colorado Boulder research. The animal study, published in the Journal of Neuroscience, found that silencing this pathway, known as the caudal granular insular cortex (CGIC), can prevent or halt chronic pain.

Gates Institute—The Gates Institute at the University of Colorado Anschutz, in partnership with CU Anschutz Innovations, has announced the recipients of its 2025 Grubstake Awards. The awardees include Wyatt Shields (CU Boulder Department of Chemical and Biological Engineering), partnering with Benjamin Bitler (CU Anschutz) on their project Macrophage Backpacks for Delivering Olaparib to High-Grade Serous Carcinomas.

CU Boulder Today—University of Colorado researchers have developed a fast, easy test that could help blood centers and hospitals monitor the quality of stored red blood cells. The palm-sized, chip-based device uses surface acoustic waves to assess cell aging, with the goal of improving transfusion outcomes and better allocating high-quality blood to patients.

CU Boulder Today—The University of Colorado (CU) and Medtronic, a global leader in health care technology, have entered into a strategic research agreement to accelerate the development of transformative health technologies. CU was selected from a nationwide search for its strength in advancing disruptive innovation.

Colorado BioScience Association (CBSA)—The state’s life sciences ecosystem raised $3.2 billion in 2025, a record driven by significant mergers and acquisitions. The results demonstrate the durability of Colorado’s life sciences community as companies, investors, and research institutions operate amid economic, regulatory, and policy uncertainty.

CU Boulder Today—Cancer is one of the leading causes of death in the U.S., second only to heart disease. But a new cancer treatment method from CU Boulder researchers uses sound waves to soften tumors and could be a potent tool against the disease.

CU Boulder College of Engineering & Applied Science—In 2025, CU Boulder celebrated its first awards from the Advanced Research Projects Agency for Health (ARPA-H). The new agency within the U.S. Department of Health and Human Services supports transformative health and biomedical breakthroughs. ARPA-H was founded in 2022 with a mission to fast-track “high-impact solutions to society’s most challenging health problems.”

CU Boulder College of Engineering and Applied Science—The technology, published in the journal Arthroscopy Techniques, completely transforms arthroscopic procedures in the hip region, making them safer and more efficient than ever before.